A detailed history of Sivia Capital Partners, LLC transactions in Amgen Inc stock. As of the latest transaction made, Sivia Capital Partners, LLC holds 1,321 shares of AMGN stock, worth $368,241. This represents 0.25% of its overall portfolio holdings.

Number of Shares
1,321
Previous 1,234 7.05%
Holding current value
$368,241
Previous $385 Million 10.4%
% of portfolio
0.25%
Previous 0.26%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 11, 2024

BUY
$309.38 - $337.38 $26,916 - $29,352
87 Added 7.05%
1,321 $426 Million
Q2 2024

Aug 05, 2024

BUY
$262.75 - $319.31 $46,244 - $56,198
176 Added 16.64%
1,234 $385 Million
Q1 2024

Apr 18, 2024

SELL
$268.87 - $324.56 $1,344 - $1,622
-5 Reduced 0.47%
1,058 $301 Million
Q4 2023

Feb 14, 2024

BUY
$255.7 - $288.46 $271,809 - $306,632
1,063 New
1,063 $306 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $149B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Sivia Capital Partners, LLC Portfolio

Follow Sivia Capital Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sivia Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sivia Capital Partners, LLC with notifications on news.